Published in Respirology on December 01, 2002
CH5424802 (RO5424802) for patients with ALK-rearranged advanced non-small-cell lung cancer (AF-001JP study): a single-arm, open-label, phase 1-2 study. Lancet Oncol (2013) 4.30
Rapid detection of epidermal growth factor receptor mutations in lung cancer by the SMart-Amplification Process. Clin Cancer Res (2007) 3.02
Phase II trial of gefitinib in combination with bevacizumab as first-line therapy for advanced non-small cell lung cancer with activating EGFR gene mutations: the Okayama Lung Cancer Study Group Trial 1001. J Thorac Oncol (2015) 2.12
Roles of toll-like receptors in C-C chemokine production by renal tubular epithelial cells. J Immunol (2002) 1.98
The role of antigenic peptide in CD4+ T helper phenotype development in a T cell receptor transgenic model. Int Immunol (2004) 1.63
Rapid SNP diagnostics using asymmetric isothermal amplification and a new mismatch-suppression technology. Nat Methods (2007) 1.48
The production of IL-10 by human regulatory T cells is enhanced by IL-2 through a STAT5-responsive intronic enhancer in the IL-10 locus. J Immunol (2008) 1.26
Impact of normothermic preservation with extracellular type solution containing trehalose on rat kidney grafting from a cardiac death donor. PLoS One (2012) 1.07
A thymus-specific noncoding RNA, Thy-ncR1, is a cytoplasmic riboregulator of MFAP4 mRNA in immature T-cell lines. BMC Mol Biol (2010) 1.04
Rapid screening assay for KRAS mutations by the modified smart amplification process. J Mol Diagn (2008) 0.95
miR-155, a Modulator of FOXO3a Protein Expression, Is Underexpressed and Cannot Be Upregulated by Stimulation of HOZOT, a Line of Multifunctional Treg. PLoS One (2011) 0.93
Use of a competitive probe in assay design for genotyping of the UGT1A1 *28 microsatellite polymorphism by the smart amplification process. Biotechniques (2007) 0.91
Comprehensive analysis of FOXP3 mRNA expression in leukemia and transformed cell lines. Leuk Res (2007) 0.90
Cell-in-cell structures formed between human cancer cell lines and the cytotoxic regulatory T-cell line HOZOT. J Mol Cell Biol (2010) 0.90
Involvement of nitrosative stress in experimental periodontitis in diabetic rats. J Clin Periodontol (2012) 0.88
Long-term survival following concurrent chemoradiotherapy in patients with non-small-cell lung cancer with concomitant brain metastases only. Int J Clin Oncol (2005) 0.88
Interleukin-8 and RANTES are signature cytokines made by HOZOT, a new type of regulatory T cells. Mol Immunol (2009) 0.87
Computational structure models of apo and diferric transferrin-transferrin receptor complexes. Protein J (2009) 0.87
IL-2 activation of STAT5 enhances production of IL-10 from human cytotoxic regulatory T cells, HOZOT. Exp Hematol (2007) 0.87
Prediction of folding pathway and kinetics among plant hemoglobins using an average distance map method. Proteins (2005) 0.86
Azithromycin may inhibit interleukin-8 through suppression of Rac1 and a nuclear factor-kappa B pathway in KB cells stimulated with lipopolysaccharide. J Periodontol (2011) 0.85
Pemetrexed and carboplatin followed by pemetrexed maintenance therapy in chemo-naïve patients with advanced nonsquamous non-small-cell lung cancer. Invest New Drugs (2013) 0.85
Advanced age is not correlated with either short-term or long-term postoperative results in lung cancer patients in good clinical condition. Chest (2005) 0.85
Evaluation of lesions corresponding to ground-glass opacities that were resected after computed tomography follow-up examination. Lung Cancer (2009) 0.85
Safety and pharmacokinetic study of nab-paclitaxel plus carboplatin in chemotherapy-naïve patients with advanced non-small cell lung cancer. Invest New Drugs (2011) 0.84
Factors affecting the local control of stereotactic body radiotherapy for lung tumors including primary lung cancer and metastatic lung tumors. Jpn J Radiol (2012) 0.84
A comparative study of odontogenic keratocysts associated with and not associated with an impacted mandibular third molar. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2002) 0.84
Effects of glucosyl hesperidin on serum lipids in hyperlipidemic subjects: preferential reduction in elevated serum triglyceride level. J Nutr Sci Vitaminol (Tokyo) (2004) 0.83
Impact of cold preservation on leukocyte adhesion to the transplanted rat lung. Microsurgery (2007) 0.82
Glucosyl hesperidin lowers serum triglyceride level in hypertriglyceridemic subjects through the improvement of very low-density lipoprotein metabolic abnormality. J Nutr Sci Vitaminol (Tokyo) (2005) 0.82
HOZOTs, novel human regulatory T-cell lines, exhibit helper or suppressor activities depending on dendritic cell or anti-CD3 stimulation. Exp Hematol (2009) 0.82
Analysis of the differences in the folding kinetics of structurally homologous proteins based on predictions of the gross features of residue contacts. Proteins (2003) 0.82
Analysis of the differences in the folding mechanisms of c-type lysozymes based on contact maps constructed with interresidue average distances. J Mol Model (2007) 0.82
Sensitive detection of EGFR mutations using a competitive probe to suppress background in the SMart Amplification Process. Biologicals (2008) 0.81
Novel mechanisms of suppressor activity exhibited by cytotoxic regulatory T cell lines, HOZOT. Exp Hematol (2008) 0.81
Detection of pairwise residue proximity by covariation analysis for 3D-structure prediction of G-protein-coupled receptors. Protein J (2004) 0.81
Instruction of naive CD4+ T-cell fate to T-bet expression and T helper 1 development: roles of T-cell receptor-mediated signals. Immunology (2007) 0.81
Dexamethasone inhibits maturation and alters function of monocyte-derived dendritic cells from cord blood. Pediatr Res (2005) 0.81
Long-term administration of second-line chemotherapy with S-1 and gemcitabine for platinum-resistant non-small cell lung cancer: a phase II study. J Thorac Oncol (2011) 0.80
Bioavailability of glucosyl hesperidin in rats. Biosci Biotechnol Biochem (2006) 0.80
IL-2-independent generation of FOXP3(+)CD4(+)CD8(+)CD25(+) cytotoxic regulatory T cell lines from human umbilical cord blood. Exp Hematol (2007) 0.80
Cytotoxicity of activated natural killer cells and expression of adhesion molecules in small-cell lung cancer. Anticancer Res (2012) 0.80
In silico study on the substrate binding manner in human myo-inositol monophosphatase 2. J Mol Model (2011) 0.79
Construction of hypothetical three-dimensional structure of P2Y1 receptor based on Fourier transform analysis. J Protein Chem (2002) 0.79
Suppression of apolipoprotein B secretion from HepG2 cells by glucosyl hesperidin. J Nutr Sci Vitaminol (Tokyo) (2006) 0.79
A phase I study of combination S-1 plus cisplatin chemotherapy with concurrent thoracic radiation for locally advanced non-small cell lung cancer. Lung Cancer (2008) 0.79
Carboplatin plus either docetaxel or paclitaxel for Japanese patients with advanced non-small cell lung cancer. Anticancer Res (2013) 0.79
Desire for information and involvement in treatment decisions: lung cancer patients' preferences and their physicians' perceptions: results from Okayama Lung Cancer Study Group Trial 0705. J Thorac Oncol (2010) 0.79
Cisplatin-induced long-term dynorphin A-immunoreactivity in cell somata of rat area postrema neurons. Neurosci Lett (2007) 0.79
Factors affecting survival time after recurrence of non-small-cell lung cancer treated with concurrent chemoradiotherapy. Jpn J Radiol (2012) 0.79
Efficacy and safety of weekly nab-paclitaxel plus carboplatin in patients with advanced non-small cell lung cancer. Lung Cancer (2013) 0.78
Incorporating into a Cα Go model the effects of geometrical restriction on Cα atoms caused by side chain orientations. Proteins (2013) 0.78
Absence of binding between the human transferrin receptor and the transferrin complex of biological toxic trace element, aluminum, because of an incomplete open/closed form of the complex. Biol Trace Elem Res (2009) 0.78
Aggregatibacter actinomycetemcomitans lipopolysaccharide stimulated epithelial cells produce interleukin-15 that regulates T cell activation. Arch Oral Biol (2013) 0.78
Analyses of protein sequences using inter-residue average distance statistics to study folding processes and the significance of their partial sequences. Protein Pept Lett (2011) 0.78
Phase I study of irinotecan and amrubicin in patients with advanced non-small-cell lung cancer. Anticancer Res (2005) 0.77
[Dysprosody associated with environmental auditory sound agnosia in right temporal lobe hypoperfusion--a case report]. Rinsho Shinkeigaku (2004) 0.77
Interleukin-12 augments cytolytic activity of peripheral blood mononuclear cells against autologous lung cancer cells in combination with IL-2. Lung Cancer (2002) 0.77
Phase I dose-escalation study evaluating safety, tolerability and pharmacokinetics of MEDI-573, a dual IGF-I/II neutralizing antibody, in Japanese patients with advanced solid tumours. Invest New Drugs (2014) 0.77
A phase I and pharmacological study of amrubicin and topotecan in patients of small-cell lung cancer with relapsed or extensive-disease small-cell lung cancer. Lung Cancer (2006) 0.77
Altered gene expression in gingival tissues and enhanced bone loss in rats with diabetes with experimental periodontitis. J Periodontol (2013) 0.76
Erythropoietin induces sustained phosphorylation of STAT5 in primitive but not definitive erythrocytes generated from mouse embryonic stem cells. Exp Hematol (2006) 0.76
[Oral osteoporosis: a review and its dental implications]. Clin Calcium (2007) 0.76
Effect of IL-15 and natural killer cells on osteoclasts and osteoblasts in a mouse coculture. Inflammation (2014) 0.76
A luminance-based heart chip assay for assessing the efficacy of graft preservation solutions in heart transplantation in rats. Heart Asia (2013) 0.76
Analyses of the folding properties of ferredoxin-like fold proteins by means of a coarse-grained Gō model: relationship between the free energy profiles and folding cores. Proteins (2013) 0.76
Vertebrobasilar infarction related to giant cell (temporal) arteritis: case report. Neurol Med Chir (Tokyo) (2013) 0.75
Fluorescence imaging in vivo visualizes delayed gastric emptying of liquid enteral nutrition containing pectin. BMC Gastroenterol (2014) 0.75
[Pulmonary non-tuberculous mycobacteriosis complicated with lung cancer]. Kyobu Geka (2014) 0.75
Marked induction of CD4+CD8+ T cells with multifunctional properties by coculturing CD2+ cells with xenogeneic stromal cells. J Immunol Methods (2011) 0.75
Local skin flap reconstruction for abdominal wound dehiscence after abdominal surgery with a stoma: report of two cases. Surg Today (2011) 0.75
[An elderly case of acute myelocytic leukemia complicated with bleeding gastric angiodysplasia, successfully treated with topical endoscopic polidocanol injection]. Nihon Ronen Igakkai Zasshi (2004) 0.75
A case of mixed connective tissue disease presenting with nephrotic syndrome. Mod Rheumatol (2004) 0.75
Potent anti-tumor killing activity of the multifunctional Treg cell line HOZOT against human tumors with diverse origins. Int J Oncol (2011) 0.75
Assessment of oral malodor and tonsillar microbiota after gargling with benzethonium chloride. J Oral Sci (2016) 0.75
Battle for violin exercise promotes "carotid plaque"? J Atheroscler Thromb (2007) 0.75
[Application of photonics technology for research of transplantation and regenerative medicine]. Nihon Rinsho (2007) 0.75
A phase I study of S-1 with concurrent thoracic radiotherapy in elderly patients with localized advanced non-small cell lung cancer. Lung Cancer (2010) 0.75
Estimation of relative binding free energy based on a free energy variational principle for the FKBP-ligand system. J Comput Aided Mol Des (2013) 0.75
Nucleotide-binding sites in V-type Na+-ATPase from Enterococcus hirae. J Biochem (2002) 0.75
[Acute myelogenous leukemia complicated with severe tumor lysis syndrome after a single day of idarubicin/cytarabine chemotherapy]. Rinsho Ketsueki (2003) 0.75
A Systematic Analysis of the Binding Affinity Between the Pim-1 Kinase and Its Inhibitors Based on the MM/3D-RISM/KH Method. J Chem Inf Model (2017) 0.75
Minimally Invasive Spinopelvic Fixation for Unstable Bilateral Sacral Fractures. Clin Spine Surg (2016) 0.75
Factor associated with failure to administer subsequent treatment after progression in the first-line chemotherapy in EGFR-mutant non-small cell lung cancer: Okayama Lung Cancer Study Group experience. Cancer Chemother Pharmacol (2014) 0.75
[Myeloid/natural killer cell precursor acute leukemia initiated with pleural effusion]. Nihon Naika Gakkai Zasshi (2002) 0.75
Stromal cells' B7-1 is a key stimulatory molecule for interleukin-10 production by HOZOT, a multifunctional regulatory T-cell line. Immunol Cell Biol (2010) 0.75
[Outcome of immunosuppressive therapy for myelodysplastic syndromes: results of 12 cases from a single institution]. Rinsho Ketsueki (2002) 0.75
Lipopolysaccharide-mediated enhancement of bone metabolism in estrogen-deficient mice. J Periodontol (2008) 0.75
[Acute myelocytic leukemia (M0) in an elderly patient with relapsed granulocytic sarcoma (M7) of bone during the second period of complete remission 5 years after onset]. Nihon Ronen Igakkai Zasshi (2003) 0.75
[A case of elderly non-small-cell lung cancer (NSCLC) treated in cooperation with a local hospital and with vinorelbine monotherapy]. Gan To Kagaku Ryoho (2005) 0.75
Engineering the substrate specificity of Alcaligenes D-aminoacylase useful for the production of D-amino acids by optical resolution. J Chromatogr B Analyt Technol Biomed Life Sci (2011) 0.75